ENTX
Price
$1.80
Change
-$0.00 (-0.00%)
Updated
Aug 8, 10:31 AM (EDT)
Capitalization
81.81M
Earnings call today
OPORF
Price
$0.24
Change
-$0.05 (-17.24%)
Updated
Feb 14 closing price
Capitalization
91.39M
Interact to see
Advertisement

ENTX vs OPORF

Header iconENTX vs OPORF Comparison
Open Charts ENTX vs OPORFBanner chart's image
Entera Bio
Price$1.80
Change-$0.00 (-0.00%)
Volume$1.98K
Capitalization81.81M
OPEN ORPHAN
Price$0.24
Change-$0.05 (-17.24%)
Volume$3K
Capitalization91.39M
ENTX vs OPORF Comparison Chart in %
Loading...
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTX vs. OPORF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTX is a Hold and OPORF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ENTX: $1.80 vs. OPORF: $0.24)
Brand notoriety: ENTX and OPORF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTX: 140% vs. OPORF: 100%
Market capitalization -- ENTX: $81.81M vs. OPORF: $91.39M
ENTX [@Biotechnology] is valued at $81.81M. OPORF’s [@Biotechnology] market capitalization is $91.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTX’s FA Score shows that 0 FA rating(s) are green whileOPORF’s FA Score has 2 green FA rating(s).

  • ENTX’s FA Score: 0 green, 5 red.
  • OPORF’s FA Score: 2 green, 3 red.
According to our system of comparison, OPORF is a better buy in the long-term than ENTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTX’s TA Score shows that 4 TA indicator(s) are bullish.

  • ENTX’s TA Score: 4 bullish, 6 bearish.

Price Growth

ENTX (@Biotechnology) experienced а -6.74% price change this week, while OPORF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

ENTX is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPORF($91.4M) has a higher market cap than ENTX($81.8M). ENTX YTD gains are higher at: -15.094 vs. OPORF (-34.871). OPORF has higher annual earnings (EBITDA): 14M vs. ENTX (-10.05M). OPORF has higher revenues than ENTX: OPORF (56M) vs ENTX (223K).
ENTXOPORFENTX / OPORF
Capitalization81.8M91.4M89%
EBITDA-10.05M14M-72%
Gain YTD-15.094-34.87143%
P/E RatioN/A11.75-
Revenue223K56M0%
Total Cash12.6MN/A-
Total Debt220KN/A-
FUNDAMENTALS RATINGS
ENTX: Fundamental Ratings
ENTX
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ENTXOPORF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
14%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
14%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ENTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKRIF14.510.46
+3.24%
Bank Ireland Group PLC
FMCCI18.100.10
+0.56%
Freddie Mac
LDGYY20.52N/A
N/A
Landis Gyr Group AG
CFXTF0.25N/A
N/A
Conifex Timber Inc.
FPLSF11.30-0.14
-1.19%
5N Plus, Inc.

ENTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTX has been loosely correlated with STOK. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTX jumps, then STOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTX
1D Price
Change %
ENTX100%
-9.09%
STOK - ENTX
33%
Loosely correlated
+0.61%
JSPR - ENTX
32%
Poorly correlated
-5.86%
OPORF - ENTX
31%
Poorly correlated
N/A
DNLI - ENTX
31%
Poorly correlated
-0.42%
IMNM - ENTX
30%
Poorly correlated
-5.64%
More

OPORF and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPORF has been loosely correlated with YMAB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OPORF jumps, then YMAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
YMAB - OPORF
34%
Loosely correlated
N/A
ENTX - OPORF
31%
Poorly correlated
-9.09%
PMN - OPORF
23%
Poorly correlated
-6.76%
EWTX - OPORF
6%
Poorly correlated
-4.18%
BCTX - OPORF
4%
Poorly correlated
+8.49%
More